Acceptance of Clinical Data for Scientific Publication - UnoMeter[TM] Safeti[TM] Max

Oslo, 26 May 2026 - Observe Medical ASA (the "Company" or "Observe Medical") is pleased to announce that an Abstract with in vitro clinical data related to the Company's UnoMeter[TM] Safeti[TM] Max has been accepted for presentation and publication by the International Continence Society.

The accepted Abstract presents findings from in vitro studies evaluating the product's ability to protect patients from Catheter Associated Urinary Tract infection (CAUTI), the most common hospital-acquired infection and a major global healthcare burden, representing a multi-billion-dollar annual cost through direct treatment expenses, prolonged hospitalization, and infection -related complications.

The Company believes the acceptance represents an important scientific validation of its technology and supports the continued commercial development of the UnoMeter[TM] portfolio.

"We are very encouraged by the acceptance of these data for publication on a respected scientific platform," said Jørgen Mann, CEO. "Peer-reviewed publication is an important step in building scientific credibility and increasing awareness of the value creation of our technology. We see that UnoMeter[TM] Safeti[TM] Max has the potential of redefining protection against catheter associated Urinary tract infection (CAUTI) and at the same time offering healthcare providers with a health-economic contribution of managing budget restraints and to support the sustainability agenda"

For further information, please contact:

Jørgen Mann, CEO Observe Medical Mobile: +45 408 67558 E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical Mobile: +47 958 12765 E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.